CYROLITE® molding compounds for the medical industry: Röhm appoints IMCD as new authorized distributor for Switzerland and Liechtenstein

• The cooperation between Röhm and IMCD, which has existed since 2020, is being extended to Switzerland and Liechtenstein.

As of February 1, 2024, IMCD N.V., headquartered in Rotterdam (The Netherlands), will also market and distribute the entire portfolio of CYROLITE® and CYROLITE® MD molding compounds for medical technology applications in Switzerland and Liechtenstein. “We are delighted that IMCD is distributing our CYROLITE® products throughout Europe from a single source,” says Michael Zietek, Director for Europe in the Molding Compounds business unit at Röhm. “We hope that this will provide a simple and efficient cross-border service for all our customers in the medical sector in Europe.” The cooperation with IMCD, which has been in place since April 2020, has been expanded to include the two previously excluded European countries of Switzerland and Liechtenstein.

Jana Zietzling, Head of Product Management Medical at IMCD Advanced Materials, adds “We are thrilled about this expansion, enabling us to reach customers in Switzerland and Liechtenstein. This step reinforces our commitment to supporting customers in their medical device development across borders, completing our European distribution network for CYROLITE® and CYROLITE® MD molding compounds.”

Röhm is a technology leader for polymethyl methacrylate (PMMA) molding compounds. Its CYROLITE® products are designed to meet the stringent requirements for medical and diagnostic devices and have proven successful in a wide range of applications for over 40 years. IMCD provides a dedicated team of technical and commercial experts who work in close relationship with customers across the EMEA region, while Röhm brings in the reliable manufacturing operations, quality products, and innovative solutions of its medical acrylics portfolio.

CYROLITE® products are transparent, impact-modified thermoplastic molding compounds specially developed for medical technology. These products are the perfect solution for applications requiring superior balance of properties as they are tough, highly transparent, bondable, sterilizable (gamma, e-beam, EtO), easy to process and resistant to chemicals. All CYROLITE® product grades are BPA-free and biocompatible in compliance with USP Class VI and ISO 10993-1. The main applications for these products are in disposable medical device and diagnostics components, such as, infusion and catheter accessories, as well as blood/plasma separators, chest drains, filters and diagnostics cassettes.